<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20201016049043N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-11-21</date_registration>
      <primary_sponsor>Zahedan University of Medical Sciences</primary_sponsor>
      <public_title>The effect of family-based empowerment model in hypertensive patients</public_title>
      <acronym></acronym>
      <scientific_title>Studying the effect of family-based empowerment model on self-efficacy and quality of life in hypertensive patients visiting comprehensive health centers</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-08-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>70</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/51746</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: Sampling will be done in several stages. First, urban areas are considered as clusters, then two areas are randomly selected, and then from each area, a center is identified by drawing a number, and the centers are allocated to intervention or control by drawing a number. Samples from selected centers will then be selected simply and consecutively and based on inclusion criteria.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Hypertension.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Family-centered empowerment based on steps or pattern according to the training program designed for each group in 4 60-minute sessions for 4 weeks individually, with the active participation of the patient and a family member (at least the main caregiver of the family) in the form of discussion and questions and answers will be done by the researcher in a suitable place for training in comprehensive health centers and preferably during office hours using teaching aids such as PowerPoint, educational videos and educational booklets and the control group will not receive any training. Step 1 (Understanding the threat): The first step in the family-centered empowerment model is to increase the intensity and sensitivity perceived in order to sensitize and raise the level of information of patients and their families through lectures and discussions about the nature and complications of the disease, aggravating factors Disease, nutritional factors, exercise and effective factors in disease control will be implemented. At the end of the training session, questions and answers will be done to ensure the understanding of the content. Step 2 (Self-Efficacy): At this stage, problem solving or problem solving will be implemented. For this purpose, problem solving sessions (two 60-minute sessions) will be held individually for patients and their families. In these sessions, patients and families will be confronted with problems and the problem-solving process, and will be asked to discuss concrete examples of their situation and what they have done to improve the problem. Also in this session, practical methods of measuring weight and blood pressure (in detail) and the consequences of not controlling these two variables and its normal amount will be explained. Patients and families will then be asked to practice this skill. At this stage, the best way to solve patients' problems will be selected and the client's skills will be emphasized. Step 3 (self-confidence and increase self-confidence): At this stage, the patient will be asked to teach the family the issues raised in the previous sessions during the session with the help of the researcher, and if help and guidance is needed, the researcher will do this. The purpose of this step is to increase patients' self-confidence due to their ability to provide information to family members and family support. To ensure and follow up on this step, a number of questions related to the training issues will be given to the patient to complete with family members and submit to the researcher (one week). Step 4 (Evaluation): Process evaluation during the process Intervention in all sessions will be done with questions and answers about the items mentioned in the previous sessions. The final evaluation will be done one and three months after the intervention in the two groups by completing the questionnaires of quality of life and self-efficacy. Also, during the research, the researcher will be in contact with the research units by phone in order to solve possible problems and questions. Intervention 2: Control group: Get routine care.In terms of observing ethical issues at the end of the intervention, an educational booklet based on valid scientific texts will be prepared under the supervision of experts in this field and will be provided to participants in both intervention and control groups.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All data is potentially shareable after unidentified individuals. Questionnaires containing information of patients in this study, including age, sex and any other information that is collected and analyzed are available.

When:
Access 5 months after the end of the intervention

To whom:
Researchers working in academic and scientific institutionوابسته به سازمان معتبر باشدs

Conditions:
Be affiliated with a reputable organization

Where to obtain:
email: mahsaa.asadollahi@gmail.com

How to obtain:
Send message via email and receive a reply within 7 working days

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr Alireza Salar</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Nursing and Midwifery, Mashahir square; Zahedan</address>
        <city>Zahedan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9816913396</zip>
        <telephone>+98 54 3344 2482</telephone>
        <email>salar293@gmail.com</email>
        <affiliation>Zahedan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr Alireza Salar</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Nursing and Midwifery, Mashahir square; Zahedan</address>
        <city>Zahedan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9816913396</zip>
        <telephone>+98 54 3344242</telephone>
        <email>salar293@gmail.com</email>
        <affiliation>Zahedan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Diagnosed high blood pressure from at least 6 months ago
Caregiver has at least reading and writing literacy 
Being at the age of 25-65 years old</inclusion_criteria>
      <agemin>25 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Participating in a training program similar to the current training program during the last 6 months</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>I10</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Essential (primary) hypertension</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>N/A</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Family-centered empowerment based on steps or pattern according to the training program designed for each group in 4 60-minute sessions for 4 weeks individually, with the active participation of the patient and a family member (at least the main caregiver of the family) in the form of discussion and questions and answers will be done by the researcher in a suitable place for training in comprehensive health centers and preferably during office hours using teaching aids such as PowerPoint, educational videos and educational booklets and the control group will not receive any training. Step 1 (Understanding the threat): The first step in the family-centered empowerment model is to increase the intensity and sensitivity perceived in order to sensitize and raise the level of information of patients and their families through lectures and discussions about the nature and complications of the disease, aggravating factors Disease, nutritional factors, exercise and effective factors in disease control will be implemented. At the end of the training session, questions and answers will be done to ensure the understanding of the content. Step 2 (Self-Efficacy): At this stage, problem solving or problem solving will be implemented. For this purpose, problem solving sessions (two 60-minute sessions) will be held individually for patients and their families. In these sessions, patients and families will be confronted with problems and the problem-solving process, and will be asked to discuss concrete examples of their situation and what they have done to improve the problem. Also in this session, practical methods of measuring weight and blood pressure (in detail) and the consequences of not controlling these two variables and its normal amount will be explained. Patients and families will then be asked to practice this skill. At this stage, the best way to solve patients' problems will be selected and the client's skills will be emphasized. Step 3 (self-confidence and increase self-confidence): At this stage, the patient will be asked to teach the family the issues raised in the previous sessions during the session with the help of the researcher, and if help and guidance is needed, the researcher will do this. The purpose of this step is to increase patients' self-confidence due to their ability to provide information to family members and family support. To ensure and follow up on this step, a number of questions related to the training issues will be given to the patient to complete with family members and submit to the researcher (one week). Step 4 (Evaluation): Process evaluation during the process Intervention in all sessions will be done with questions and answers about the items mentioned in the previous sessions. The final evaluation will be done one and three months after the intervention in the two groups by completing the questionnaires of quality of life and self-efficacy. Also, during the research, the researcher will be in contact with the research units by phone in order to solve possible problems and questions.</i_keyword>
      <i_keyword>Control group: Get routine care.In terms of observing ethical issues at the end of the intervention, an educational booklet based on valid scientific texts will be prepared under the supervision of experts in this field and will be provided to participants in both intervention and control groups.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Self-efficacy score in the specific self-efficacy questionnaire of hypertensive patients. Timepoint: At the beginning of the study (before the intervention) and 1 month and 3 months after the intervention. Method of measurement: Specific self-efficacy of hypertensive patients questionnaire.</prim_outcome>
      <prim_outcome>Quality of life score in the quality of life questionnaire specific to hypertensive patients. Timepoint: Measurement of quality of life at the beginning of the study (before the intervention) and 1 month and 3 months after the intervention. Method of measurement: Quality of life questionnaire specific to hypertensive patients.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Zahedan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-08-10</approval_date>
        <contact_name>Ethics committee of Zahedan University of Medical Sciences</contact_name>
        <contact_address>Medical Sciences Campus, Dr. Hesabi square, Zahedan Zahedan Sistan-va-Balouchestan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
